Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. reported revenue of $2.53B for the fiscal year ended Dec 31, 2025, up 20.0% from $2.11B the year before. Net income was $451.12M, a net margin of 17.8% (prior year: $404.39M). At the end of that fiscal year the company reported total assets of $1.98B and shareholders' equity of $459.07M.
Revenue
$2.53B
+20.0% vs prior year
Net income
$451.12M
Net margin 17.8%
Diluted EPS
$15.28
USD per share
Total assets
$1.98B
At Dec 31, 2025
Equity
$459.07M
At Dec 31, 2025
Shares outstanding
28M
As of Oct 16, 2026
Explore Medpace Holdings, Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 22, 2026
- 10-QFiled Jul 23, 2026
- 10-QFiled Apr 23, 2026
- 10-KFiled Feb 10, 2026
- 10-QFiled Oct 23, 2025
- 10-QFiled Jul 22, 2025
Source: SEC EDGAR XBRL company facts for CIK 1668397 (raw data). Most recent filing in this dataset: 10-Q filed Oct 22, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.